- 201. vascular endothelium permeability
- [ ] (UMLS (CSP) C0597637) =Organ or Tissue Function ;
=cardiovascular function;
| - 251. VAV 1 Oncogene Gene
- [This gene plays a role in signal transduction. It is involved in the development and activation of both B cells and T cells. ( NCI )] (UMLS (NCI) C1336926) VAV1;
VAV1 Gene;
=Gene or Genome |
- 202. Vascular Hamartoma
- (UMLS (NCI) C0265973) =Congenital Abnormality ;
| - 252. VAV 2 Oncogene Gene
- [This gene plays a role in signal transduction and negative regulation of T-cell activation. ( NCI )] (UMLS (NCI) C0812239) VAV2;
VAV2 Gene =Gene or Genome |
- 203. Vascular Headache
- [Secondary headache disorders attributed to a variety of cranial or cervical vascular disorders, such as BRAIN ISCHEMIA; INTRACRANIAL HEMORRHAGES; and CENTRAL NERVOUS SYSTEM VASCULAR MALFORMATIONS. ( MSH )] (UMLS (NCI) C0042376) =Disease or Syndrome =CEREBROVASC DISEASE NOS;
Headache Disorders =Cefalea a grappolo;
Cefalea a tension;
Emicrania | - 253. VAV 3 Oncogene Gene
- [This gene plays a role in signal transduction and modulation of cell morphology. It is also involved in the regulation of platelet activation. ( NCI )] (UMLS (NCI) C1336927) VAV3;
VAV3 Gene;
=Gene or Genome |
- 204. vascular hemophilia
- [hemophilioid disorder due to deficiency of Von Willebrand factor and thus of Factor VIII complex. ( CSP )] (UMLS (CSP) C0042974) =Disease or Syndrome =blood coagulation disorder;
Blood Platelet Disorders;
HEMORRHAGIC COND NOS;
Genetic Condition;
Coagulation Protein Disorders;
| - 254. VAV Family Gene
- [VAV Family Genes (VAV1, VAV2, and VAV3) encode VAV proteins that respond to similar cell surface receptor tyrosine kinases as GEFs for Rho/Rac family GTPases, which activate pathways leading to actin cytoskeletal rearrangements, transcriptional alterations, cell differentiation, and/or cell proliferation. VAV proteins contain CH, DH, PH, SH2, SH3, and zinc-dependent phorbol-ester and DAG binding domains. VAV1 is expressed exclusively in hematopoietic cells, while VAV2 and VAV3 are more broadly expressed. (NCI) ( NCI )] (UMLS (NCI) C1336928) =Gene or Genome
|
- 205. Vascular Hemorrhagic Disorder
- (UMLS (NCI) C0851563) =Disease or Syndrome ;
| - 255. VAV2
- [A member of the VAV oncogene family, VAV2 is a probable exchange factor for a RAS-like GTP-binding protein and responds to a cell surface receptor tyrosine kinase. Integrin-induced phosphorylation of VAV2 requires SYK. VAV2 contains a calponin-homology domain, a DBL-homology domain, a PH domain, a DAG binding domain, an SH2 domain, and SH3 domains. (from OMIM 600428 and NCI) ( NCI )] (UMLS (NCI) C0297681) =Amino Acid, Peptide, or Protein; Biologically Active Substance
|
- 206. Vascular lesions of cord complicating labor and delivery
- [ ] (UMLS (ICD9CM) C0157299) =Disease or Syndrome
| - 256. VAV3
- [Encoded by human VAV3 Gene (VAV Family), the 847-amino acid VAV-3 Protein exhibits similarity to VAV1 and VAV2. Alpha and beta isoforms are expressed in peripheral blood lymphocytes, spleen, brain, thymus, heart, kidney, liver, placenta, and lung. VAV3 contains DBL and pleckstrin homology domains, a calponin homology region, an acidic motif, a DAG binding domain, two SH3 regions, and a SH2 domain. VAV3.1 Protein variant contains only the C-terminal SH3-SH2-SH3 region. Regulating the actin cytoskeleton and transcription, VAV3 acts as a GEF on RHOA, RHOG, and RAC1. VAV1, VAV2, and VAV3 respond to similar cell surface receptor tyrosine kinases. VAV3 is rapidly phosphorylated on TCR or EGFR activation. VAV1 and VAV3 enhance NFKB-dependent transcription. Integrin-induced phosphorylation requires SYK. (OMIM, Swiss-Prot, LocusLink, and NCI) ( NCI )] (UMLS (NCI) C0904737) VAV3 Protein;
VAV-3 Protein =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
|
- 207. Vascular Morphologic Change
- (UMLS (NCI) C1336951) =Finding ;
| - 257. VCL
- [actin-binding structural protein which serves to link microfilaments to other organelles in a variety of cell types. ( CSP )] (UMLS (NCI) C0085175) =Amino Acid, Peptide, or Protein; Biologically Active Substance =ABP;
|
- 208. vascular motor function
- [ ] (UMLS (CSP) C0599594) =Organ or Tissue Function ;
| - 258. VCL
- [This gene plays a role in cytoskeletal regulation and cellular adhesion. ( NCI )] (UMLS (NCI) C1336929) VCL Gene;
Vinculin Gene;
=Gene or Genome |
- 209. VASCULAR MYELOPATHIES
- (UMLS (ICD9CM) C0154685) =Disease or Syndrome ;
| - 259. VDAC1
- [This gene is involved in the regulation of small molecule transport through the outer mitochondrial membrane. ( NCI )] (UMLS (NCI) C1336930) VDAC1 Gene;
Voltage-Dependent Anion Channel 1 Gene;
=Gene or Genome |
- 210. Vascular Neurology
- (UMLS (HL7) C1555873) =Intellectual Product =Psychiatry & Neurology;
| - 260. VDAC2
- [This gene is involved in small molecule transport and apoptotic regulation. ( NCI )] (UMLS (NCI) C1336931) VDAC2 Gene;
Voltage-Dependent Anion Channel-2 Gene;
=Gene or Genome |
- 211. Vascular Proliferation
- (UMLS (NCI) C0700080) =Pathologic Function ;
| - 261. VDAC3
- [This gene plays a role in voltage-dependent anion channel regulation. ( NCI )] (UMLS (NCI) C1336932) VDAC3 Gene;
Voltage-Dependent Anion Channel-3 Gene;
=Gene or Genome |
- 212. Vascular Purpura
- (UMLS (NCI) C1368065) =Finding
| - 262. VDR
- [This gene plays a role in transcriptional regulation and in vitamin D3 metabolism. ( NCI )] (UMLS (NCI) C0919430) VDR Gene;
Vitamin D (1,25- Dihydroxyvitamin D3) Receptor Gene =Gene or Genome ;
|
- 213. vascular reactivity
- [ ] (UMLS (CSP) C1660757) =Clinical Attribute ;
| - 263. VE
- [A country in Northern South America, bordering the Caribbean Sea and the North Atlantic Ocean, between Colombia and Guyana. (NCI) ( NCI )] (UMLS (NCI) C0042469) =Geographic Area
|
- 214. vascular resistance
- [opposition to blood flow in a vascular bed. ( CSP )] (UMLS (CSP) C0042380) =Physiologic Function =hemodynamics;
| - 264. Veal
- [Cattle raised for veal meat production. Implicit is the husbandry method. ( HL7V3.0 )] (UMLS (HL7) C1561492) =Intellectual Product =LivingSubjectProductionClass;
|
- 215. vascular smooth muscle
- [nonstriated involuntary muscle tissue of blood vessels. ( CSP )] (UMLS (CSP) C0026844) =Tissue ;
=blood vessel;
Smooth Muscle | - 265. vector (nucleic acid mobility)
- [ ] (UMLS (CSP) C0599569) =Nucleic Acid, Nucleoside, or Nucleotide ;
|
- 216. Vascular Sonography
- (UMLS (HL7) C1552365) =Intellectual Product =Radiologic Technologist;
| - 266. vector cardiography
- [recording of the moment to moment electromotive forces of the heart on a plane of the body surface delineated as a vector function of time. ( CSP )] (UMLS (CSP) C0042434) =Diagnostic Procedure =ECG;
|
- 217. Vascular Specialist
- (UMLS (HL7) C1552370) =Intellectual Product =Specialist/Technologist Cardiovascular;
| - 267. vector magnetocardiography
- [ ] (UMLS (CSP) C0599595) =Diagnostic Procedure ;
|
- 218. Vascular Surgery
- (UMLS (HL7) C1555890) =Intellectual Product =surgeon;
| - 268. VECTORCARDIOGRAM
- [ ] (UMLS (ICD9CM) C0199605) =Diagnostic Procedure
|
- 219. Vascular System
- [The cardiovascular and lymphatic systems, collectively. ( NCI )] (UMLS (NCI) C0489903) =Body System ;
| - 269. Veda
- (UMLS (HL7) C1552070) =Idea or Concept =Religious Affiliation;
|
- 220. Vascular Ultrasound
- (UMLS (HL7) C1548008) =Intellectual Product =Diagnostic Service Section ID;
| - 270. VEDACLIDINE
- (UMLS (NCI) C1098956) =Organic Chemical; Pharmacologic Substance ;
|
- 221. Vascular-Interventional Technology
- (UMLS (HL7) C1552366) =Intellectual Product =Radiologic Technologist;
| - 271. Vedaprofen
- (UMLS (NCI) C0909493) =Organic Chemical
|
- 222. vasculogenesis
- [The differentiation of endothelial cells from progenitor cells during blood vessel development, and the de novo formation of blood vessels and tubes. [PMID:8999798] ( GO )] (UMLS (CSP) C1123009) =Organ or Tissue Function
| - 272. VEE virus
- [causes encephalomyelitis in horses, mules, and man; infection reservoir in birds, transmitted by mosquitoes; distribution in South America (including Venezuela), Mexico, and Florida. ( CSP )] (UMLS (CSP) C0014049) =Virus ;
=Alphavirus;
|
- 223. vasectomy
- [(vas-EK-toe-mee) An operation to cut or tie off the two tubes that carry sperm out of the testicles. ( NCI )] (UMLS (NCI) C0042387) =Therapeutic or Preventive Procedure
| - 273. VEE, inactivated
- [Venezuelan equine encephalitis, inactivated ( HL7V3.0 )] (UMLS (HL7) C1548489) =Pharmacologic Substance; Immunologic Factor ;
=Vaccines administered (code = CVX)(parenteral, unless oral is noted);
VaccineType |
- 224. Vasectomy and ligation of vas deferens
- [ ] (UMLS (ICD9CM) C0177127) =Therapeutic or Preventive Procedure
| - 274. VEE, live
- [Venezuelan equine encephalitis, live, attenuated ( HL7V3.0 )] (UMLS (HL7) C1548488) =Pharmacologic Substance; Immunologic Factor ;
=Vaccines administered (code = CVX)(parenteral, unless oral is noted);
VaccineType |
- 225. VASECTOMY STATUS
- [ ] (UMLS (ICD9CM) C0695265) =Finding
| - 275. VEE, NOS
- [Venezuelan equine encephalitis vaccine, NOS ( HL7V3.0 )] (UMLS (HL7) C1548494) =Pharmacologic Substance; Immunologic Factor ;
=Vaccines administered (code = CVX)(parenteral, unless oral is noted);
VaccineType |
- 226. Vaseline
- (UMLS (NCI) C0728774) =Organic Chemical; Biomedical or Dental Material ;
| - 276. Vegadex
- (UMLS (NCI) C0148279) =Organic Chemical; Pharmacologic Substance ;
|
- 227. Vaseretic
- (UMLS (NCI) C0633761) =Organic Chemical; Pharmacologic Substance
| - 277. Vegan Diet
- [Men who eat a vegan diet have lower levels of IGF-I, a protein associated with prostate cancer. These findings suggest that a diet without meat or dairy products could reduce the risk of prostate cancer. (from Medscape) ( NCI )] (UMLS (NCI) C0344353) =Finding ;
|
- 228. Vasin Gishu disease virus
- [ ] (UMLS (CSP) C0599180) =Virus ;
| - 278. vegetarian diet
- [dietary practice of completely avoiding meat products in the diet. ( CSP )] (UMLS (CSP) C0311164) =Therapeutic or Preventive Procedure =diet;
|
- 229. Vaso-Occlusive Disease
- [Disorder in which veins are partially or completely obstructed or the blood flow through the veins is suboptimal.--2004 ( NCI )] (UMLS (NCI) C0948441) Veno-Occlusive Disease;
VOD;
=Disease or Syndrome | - 279. VEGF121
- (UMLS (NCI) C0376853) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
|
- 230. vasoactive agent
- [ ] (UMLS (CSP) C0597639) =Pharmacologic Substance ;
=[CV000] CARDIOVASCULAR MEDICATIONS;
=2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one;
renin angiotensin system;
vasoconstrictor;
Vasodilating Agent;
| - 280. VEGF145
- (UMLS (NCI) C0525171) =Amino Acid, Peptide, or Protein; Biologically Active Substance
|
- 231. Vasoactive Intestinal Peptide Gene
- [This gene is involved in neuroendocrine mediation and anti-inflammatory immune responses. ( NCI )] (UMLS (NCI) C1366646) VIP;
VIP Gene =Gene or Genome | - 281. VEGF165
- (UMLS (NCI) C0376854) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
|
- 232. Vasoactive Intestinal Peptide Producing Neoplasm
- [An often clinically aggressive endocrine neoplasm located in the pancreas or small intestine. It is composed of cells containing vasoactive intestinal peptide. It may cause intractable diarrhea and metabolic disturbances. ( NCI )] (UMLS (NCI) C0011993) =Neoplastic Process =Carcinoma, Islet Cell;
| - 282. VEGF183
- (UMLS (NCI) C0752432) =Amino Acid, Peptide, or Protein; Biologically Active Substance
|
- 233. Vasoactive Intestinal Peptide Receptor 1 Gene
- [This gene is involved in the regulation of intestinal cell processes that are affected by vasoactive intestinal peptides. ( NCI )] (UMLS (NCI) C1336936) VIPR1;
VIPR1 Gene;
=Gene or Genome | - 283. VEGF189
- (UMLS (NCI) C0376855) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
|
- 234. vasoconstriction
- [narrowing of the blood vessels without anatomic change. ( CSP )] (UMLS (CSP) C0042396) =Organ or Tissue Function =vasomotion;
Vascular Tone Alteration =Arterial Vasoconstriction;
Venous Vasoconstriction;
| - 284. VEGF206
- (UMLS (NCI) C0376856) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
|
- 235. vasoconstrictor
- [Drugs used to cause constriction of the blood vessels. ( MSH )] (UMLS (CSP) C0042397) =Pharmacologic Substance =vasoactive agent;
=Adrenal;
METHOXAMINE;
SUMATRIPTAN;
endothelin;
| - 285. Vehem
- (UMLS (NCI) C0733481) =Carbohydrate; Pharmacologic Substance ;
|
- 236. vasodilatation
- [state of increased caliber of the blood vessels. ( CSP )] (UMLS (CSP) C0042401) =Physiologic Function =blood vessel disorder;
vasomotion;
Vascular Tone Alteration;
=Arterial Vasodilation;
Venous Vasodilation;
| - 286. VEHICLE ACCIDENTS NOT ELSEWHERE CLASSIFIABLE
- [ ] (UMLS (ICD9CM) C1955551) =Human-caused Phenomenon or Process
|
- 237. Vasodilating Agent
- [Drugs used to cause dilation of the blood vessels. ( MSH )] (UMLS (NCI) C0042402) =Pharmacologic Substance =vasoactive agent;
=kinin;
NICARDIPINE;
NIMO;
3,7-Dihydro-3,7-dimethyl-1-(5-oxohexyl)-1H-purine-2,6-dione;
PHM27;
FENOLDOPAM;
coronary vasodilator | - 287. vehicle emissions
- [Gases, fumes, vapors, and odors escaping from the cylinders of a gasoline or diesel internal-combustion engine. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed & Random House Unabridged Dictionary, 2d ed) ( MSH )] (UMLS (CSP) C0004380) =Hazardous or Poisonous Substance ;
|
- 238. vasomotion
- [change in diameter of blood vessels. ( CSP )] (UMLS (CSP) C0597640) =Organ or Tissue Function ;
=cardiovascular function;
=vasoconstriction;
vasodilatation;
pulse pressure wave;
neural control of vascular smooth muscle;
| - 288. Vehicle Modifications
- [A contractor who makes modifications to private vehicles to accommodate a health condition. ( HL7V3.0 )] (UMLS (HL7) C1556025) =Intellectual Product =Contractor;
|
- 239. Vasopressin Receptor
- [The biologic effects of arginine vasopressin (AVP) are mediated by 3 receptor subtypes: the V1A and V1B receptors that activate phospholipases via Gq/11, and the V2 receptor that activates adenylyl cyclase by interacting with GS. This subfamily of G-protein coupled receptors also includes OXT receptors. Their activity is mediated by G proteins which stimulate a phosphatidylinositol-calcium second messenger system. All are involved in the control of body fluid osmolality, blood volume, blood pressure, and vascular tone. (from OMIM) ( NCI )] (UMLS (NCI) C0078077) =Amino Acid, Peptide, or Protein; Receptor ;
| - 289. vehicular accident
- [an unforeseen and unplanned event or circumstance frequently causing loss or injury in any vehicle; this includes automobiles, trains, planes, motorcycles, boats, bicycles, etc. ( CSP )] (UMLS (CSP) C0683911) =Phenomenon or Process ;
=accident;
|
- 240. vasopressin resistant diabetes insipidus
- [ ] (UMLS (CSP) C0677501) =Disease or Syndrome ;
| - 290. Veillonella
- [A genus of gram-negative, anaerobic cocci parasitic in the mouth and in the intestinal and respiratory tracts of man and other animals. ( MSH )] (UMLS (CSP) C0042446) =Bacterium
|
- 241. vasospasm
- [spasm of the blood vessels resulting in decrease in their caliber. ( CSP )] (UMLS (CSP) C0085616) =Pathologic Function =blood vessel disorder;
| - 291. vein
- [vessel carrying blood towards the heart. ( CSP )] (UMLS (CSP) C0042449) =Body Part, Organ, or Organ Component =blood vessel;
Body Part =jugular vein;
Hepatic Portal Vein;
pulmonary vein |
- 242. Vasotec
- (UMLS (NCI) C0728763) =Amino Acid, Peptide, or Protein; Pharmacologic Substance
| - 292. Vein Disorder
- (UMLS (NCI) C0235522) =Disease or Syndrome
|
- 243. vasotocin
- [a nonapeptide hormone having both vasopressin- and oxytocin-like activities, occurring in birds, fish, and amphibians. ( CSP )] (UMLS (CSP) C0042418) =Amino Acid, Peptide, or Protein; Neuroreactive Substance or Biogenic Amine; Hormone =[HS702] POSTERIOR PITUITARY;
reproductive hormone | - 293. Vein Endothelium
- (UMLS (NCI) C1179027) =Tissue ;
|
- 244. VASOTOMY
- (UMLS (ICD9CM) C0042416) =Therapeutic or Preventive Procedure
| - 294. vein occlusion
- [obstruction or closure decreasing the capacity of a vein to supply sufficient blood flow. ( CSP )] (UMLS (CSP) C0241669) =Pathologic Function =blood vessel occlusion;
|
- 245. VASP
- [ ] (UMLS (CSP) C0255567) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 295. Velban
- (UMLS (NCI) C0728761) Velbe =Organic Chemical; Pharmacologic Substance
|
- 246. Vassar-Culling stain
- [Stain, Vassar-Culling ( HL7V3.0 )] (UMLS (HL7) C1293944) =Laboratory Procedure =ObservationMethod;
| - 296. Vellus Hair Cyst
- (UMLS (NCI) C0345997) =Neoplastic Process
|
- 247. Vastus Lateralis
- (UMLS (HL7) C0224444) =Body Part, Organ, or Organ Component =Body Part;
| - 297. VELO-CARDIO-FACIAL SYND
- [caused by microdeletion on chromosome 22q11.2; associated with multiple congenital anomalies, learning disabilities, behavioral phenotypes including ADHD and anxiety, with schizophrenic risk in adulthood. ( CSP )] (UMLS (ICD9CM) C0220704) =Congenital Abnormality; Disease or Syndrome =Chromosomal anomalies;
syndrome |
- 248. VATS
- [Endoscopic surgery of the pleural cavity performed with visualization via video transmission. ( NCI )] (UMLS (NCI) C0752151) Video-assisted Thoracic Surgery;
=Therapeutic or Preventive Procedure | - 298. velocity of light
- [299792458 m/s ( HL7V3.0 )] (UMLS (HL7) C1551069) =Quantitative Concept =UnitOfMeasureAtomInsens;
UnitOfMeasureAtomSens |
- 249. Vault
- (UMLS (HL7) C1550319) =Body Part, Organ, or Organ Component =Body Part;
| - 299. Velosef
- (UMLS (NCI) C0699948) =Organic Chemical; Antibiotic ;
|
- 250. VAV
- [VAV1 protein is a proto-oncogene product with features of a transcription factor, including an N-terminal acidic region, a proline-rich region, and two zinc finger-like domains. VAV also has an SH2, two SH3, and a guanosine exchange factor domain. Truncation of its N-terminus, containing an HLH domain and leucine zipper, activates its oncogenic potential. Wild type VAV is transcribed in hematopoietic cells, including erythroid, lymphoid, and myeloid lineages. VAV-dependent signaling pathways regulate the maturation of T-cells. (from OMIM 164875 and NCI) ( NCI )] (UMLS (NCI) C1451772) VAV1;
VAV1 Gene Product;
VAV1 Protein;
=Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 300. Velsar
- (UMLS (NCI) C0919392) =Organic Chemical; Pharmacologic Substance
|
home
